Chinese multiple dose escalation (MDE) high dose study

Trial Identifier:	D5671C00005
Sponsor:	AstraZeneca
NCTID::	NCT05437848
Start Date:	February 2022
Primary Completion Date:	December 2022
Study Completion Date:	December 2022
Condition:	Endocrine - Other

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language	Description
	English Version
	Simplified Chinese (China)

Stay informed about new Trial Results Summaries with our email notification service

Trial Locations

Country	Location
CN	Guangzhou, CN, 510515
CN	Nanjing, CN, 210012

Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.